Live
- India among top 10 countries with AI readiness: Report
- UNICEF to support Kerala's children with special needs
- Meta purges over 2 million accounts linked to scam centres
- Mumbai, Delhi ranked among top 5 prime residential markets in Asia-Pacific
- Russia provided North Korea with anti-air missiles in exchange for troop deployment
- PCB appoints Azhar Ali as head of youth development
- Deepam-2 Scheme Reaches 5 Million Beneficiaries in Three Weeks, says Nadendla Manohar
- Will RG Kar tragedy impact Bengal bypoll results?
- BGT 2024:25: Josh Hazlewood picks four as Australia bundle out India for 150
- BRS rallies support for Lagacharla ‘victims’
300 million doses of Covid vaccine ready by Dec: Serum Institute of India
Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential coronavirus vaccine will be made available by December
New Delhi: Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential coronavirus vaccine will be made available by December.
With the trials of Covid-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, Adar Poonawalla of the Serum Institute of India (SII) has said at least 300 million doses of the potential vaccine will be ready by December.
In an interview to India Today, Poonawalla said, "Each dose has 10 vials and Covishield is going to be the first Covid-19 vaccine we hope to launch if trials are successful in the UK and India."
He said that they expect the vaccine to reach the people of India in large numbers by the first quarter of 2021. The vaccine will cost around Rs 1,000 in India, he added.
